Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Operational Barriers to Precision Genomic Testing in Hematologic Malignancies: A Qualitative Study

AML - 526

Operational Barriers to Precision Genomic Testing in Hematologic Malignancies: A Qualitative Study

Summiya Nasim

Poster Presenter: Summiya Nasim

Thumbnail for Timing of TP53 Mutation Acquisition as a Determinant of Outcomes in Patients with Myeloproliferative Neoplasms and Myeloproliferative Neoplasms/ Myelodysplastic Syndromes.

MPN - 528

Timing of TP53 Mutation Acquisition as a Determinant of Outcomes in Patients with Myeloproliferative Neoplasms and Myeloproliferative Neoplasms/ Myelodysplastic Syndromes.

Sharan Jhaveri

Poster Presenter: Sharan Jhaveri

Thumbnail for Impact of Donor Type on GVHD and Survival in Pediatric Haploidentical HSCT: A 10-Year Single-Center Study

Previous 1...38 39 40 41 42 43 44...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

CT - 529

Impact of Donor Type on GVHD and Survival in Pediatric Haploidentical HSCT: A 10-Year Single-Center Study

PAULINA GARCIA MALDONADO

Poster Presenter: PAULINA GARCIA MALDONADO

$Thumbnail for Outpatient CAR-T Therapy for Relapsed/Refractory Lymphoma: A Single-Center Experience$

CT - 531

Outpatient CAR-T Therapy for Relapsed/Refractory Lymphoma: A Single-Center Experience

Aditi Saha

Poster Presenter: Aditi Saha

Thumbnail for AML Ferroptosis Induces Immunogenic Cell Death Signals and Enhances CD70-CAR-NK-Mediated Anti-Tumor Immunity

AML - 534

AML Ferroptosis Induces Immunogenic Cell Death Signals and Enhances CD70-CAR-NK-Mediated Anti-Tumor Immunity

Ran Zhao

Poster Presenter: Ran Zhao

$Thumbnail for Disease Aggressiveness Index: A Novel Pre-Infusion Risk Stratification Tool for Idecabtagene Vicleucel in Relapsed/Refractory Multiple Myeloma$

CT - 535

Disease Aggressiveness Index: A Novel Pre-Infusion Risk Stratification Tool for Idecabtagene Vicleucel in Relapsed/Refractory Multiple Myeloma

Abat Khan

Poster Presenter: Abat Khan

Thumbnail for Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review

ABCL - 537

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review

Motaz Almahmood

Poster Presenter: Motaz Almahmood

Thumbnail for THE VEXUS- MDS INTERFACE: INTEGRATING MORPHOLOGICAL MARKERS AND CLONAL EVOLUTION TO PREDICT RESPONSE TO TARGETED MYELOID CELL THERAPIES

MDS - 540

THE VEXUS- MDS INTERFACE: INTEGRATING MORPHOLOGICAL MARKERS AND CLONAL EVOLUTION TO PREDICT RESPONSE TO TARGETED MYELOID CELL THERAPIES

Teshika Yalla

Poster Presenter: Teshika Yalla

Thumbnail for Real-World Evaluation of First-Line and Second-Line Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia in Chronic Phase: The ASC4REAL-2 Phase 4 Study

CML - 541

Real-World Evaluation of First-Line and Second-Line Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia in Chronic Phase: The ASC4REAL-2 Phase 4 Study

Hagop Kantarjian

Poster Presenter: Hagop Kantarjian

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors